Adverse effects may include dry mouth, anxiety, restlessness, tremor, insomnia, tachycardia, cardiac arrhythmias, palpitations, hypertension, nausea, vomiting, headache and occasionally urinary retention in males and skin rashes. Hallucinations have been reported rarely, particularly in children.
Skin and subcutaneous tissue disorders:
Frequency unknown: Severe skin reactions, including acute generalized exanthematous pustulosis (AGEP).
Gastrointestinal Disorders
Frequency unknown: Ischaemic colitis
Eye disorders
Frequency unknown: Ischaemic optic neuropathy
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.